Volition Announces Detection of Over 95% of Early-Stage Cancers
Blinded validation cohort achieves over 95% sensitivity for stage I & II cancers with 95% specificity Capture-Seq™ Targets $36 Billion TAM in Early Cancer... Read more.
Axtria Recognized as Frost & Sullivan’s 2025 Global Company of the Year in Pharma Commercial Solutions
Honored for AI-Driven Innovation, Measurable Client Impact, and Industry-Leading Commercialization Excellence BERKELEY HEIGHTS, N.J., March 25, 2026 /PRNewswire/... Read more.
ADP Research: Only 22% of Workers Confident Their Job is Safe from Elimination, Underscoring the Importance of Talent Strategies that Prepare Employees for the Future
Latest issue of Today at Work captures the pulse of global workforce sentiment to uncover how AI advances and changing demographics offer new challenges and opportunities... Read more.
Villa Vie Odyssey Receives UNESCO Accreditation of Peace
FORT LAUDERDALE, Fla., March 25, 2026 /PRNewswire/ — Villa Vie Residences today announced that its flagship vessel, Villa Vie Odyssey, has been provisionally... Read more.
Up to 20 AI Firewall Vendors Face First Independent Security Validation
32 real-world validation scenarios across three security layers evaluate whether AI security products stop attacks or just claim to — OWASP and MITRE ATLAS-aligned,... Read more.
PA-AI Expands Leadership Team as It Advances a New Approach to Guiding AI Through Human Perception, Trust, and Adoption
New Operating Board members and Chief Product Officer strengthen governance, product development, and enterprise expertise LOS ANGELES, March 25, 2026 /PRNewswire/... Read more.
How Vingroup and VinFast Are Building a Green-Tech Ecosystem for Global Expansion
HANOI, Vietnam, March 25, 2026 /PRNewswire/ — When electric SUVs bearing the VinFast badge begin to appear on the roads of California or North Carolina, they... Read more.
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed
Tegavivint Targets the Central Oncogenic Driver in Colorectal Cancer as First-in-Class Clinical-Stage Wnt/β-Catenin Inhibitor CRC Expansion Builds on Promising... Read more.
YY Group Holding Announces Estimated Total Assets and Net Assets per Share of $8.03 and $3.18, Respectively, for Fiscal Year 2025
Estimates Reflect $34.3M in Total Assets and $13.6M in Net Assets Following Share Consolidation SINGAPORE, March 25, 2026 /PRNewswire/ — YY Group Holding... Read more.
Geneva becomes world’s capital of AI in July for ITU’s AI for Good Global Summit
Flagship summit to showcase AI breakthroughs back-to-back with inaugural UN Global Dialogue on AI Governance. GENEVA, March 25, 2026 /PRNewswire/ — As governments... Read more.